Success Metrics

Clinical Success Rate
78.6%

Based on 11 completed trials

Completion Rate
79%(11/14)
Active Trials
0(0%)
Results Posted
73%(8 trials)
Terminated
3(21%)

Phase Distribution

Ph phase_2
1
7%
Ph not_applicable
10
71%
Ph phase_1
2
14%
Ph phase_4
1
7%

Phase Distribution

2

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
2(14.3%)
Phase 2Efficacy & side effects
1(7.1%)
Phase 4Post-market surveillance
1(7.1%)
N/ANon-phased studies
10(71.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

78.6%

11 of 14 finished

Non-Completion Rate

21.4%

3 ended early

Currently Active

0

trials recruiting

Total Trials

14

all time

Status Distribution
Completed(11)
Terminated(3)

Detailed Status

Completed11
Terminated3

Development Timeline

Analytics

Development Status

Total Trials
14
Active
0
Success Rate
78.6%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (14.3%)
Phase 21 (7.1%)
Phase 41 (7.1%)
N/A10 (71.4%)

Trials by Status

completed1179%
terminated321%

Recent Activity

0 active trials
Showing 5 of 14
completednot_applicable

Preliminary Investigation of Novel Methods to Reduce Children's Secondhand Smoke Exposure

NCT01935713
terminatednot_applicable

Analysis of Aldehyde Biomarkers of Exposure and Host Response

NCT00482690
completednot_applicable

Validation of Biomarkers of Exposure and Host Response

NCT00468234
completednot_applicable

RCT of an Internet Cessation Program Plus Online Social Network for HIV+ Smokers

NCT02781090
completednot_applicable

Babies Living Safe and Smokefree

NCT02602288
View all 14 trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT01935713Not Applicable

Preliminary Investigation of Novel Methods to Reduce Children's Secondhand Smoke Exposure

Completed
NCT00482690Not Applicable

Analysis of Aldehyde Biomarkers of Exposure and Host Response

Terminated
NCT00468234Not Applicable

Validation of Biomarkers of Exposure and Host Response

Completed
NCT02781090Not Applicable

RCT of an Internet Cessation Program Plus Online Social Network for HIV+ Smokers

Completed
NCT02602288Not Applicable

Babies Living Safe and Smokefree

Completed
NCT02869451Not Applicable

Mobile Contingency Management for Marijuana and Tobacco Cessation

Completed
NCT02873754Not Applicable

Smoking Treatment and Exercise Program for Underserved Populations (STEP UP)

Completed
NCT02346539Phase 1

Effect of Nicotine on Brain Reward Pathways

Completed
NCT01896518Not Applicable

Novel Methods to Reduce Children's Secondhand Smoke Exposure II

Completed
NCT01830842Not Applicable

Acute and Chronic Nicotine Modulation of Reinforcement Learning

Completed
NCT01359709Phase 1

Effects of Contingency Management and Nicotine Replacement Therapy on Youth Smoking

Completed
NCT01925781Phase 4

e-Cigarettes Versus NRT Gum for Smoking Cessation

Terminated
NCT01451814Phase 2

Development of Positive Psychotherapy for Smoking Cessation

Completed
NCT01465074Not Applicable

Effects of Acute Nicotine Treatment on Neuroplasticity and Memory in Patients With Schizophrenia

Terminated

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14